NovaBay Pharmaceuticals, Inc.
NBY
$1.03
$0.010.49%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 197.55% | 611.58% | 364.45% | -85.29% | -77.65% |
| Total Receivables | -38.49% | -90.68% | -57.49% | -42.79% | -23.14% |
| Inventory | -- | -33.29% | -- | 52.69% | -86.11% |
| Prepaid Expenses | -61.62% | -32.92% | -57.56% | -24.61% | 12.80% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -26.72% | 54.26% | 50.00% | -94.34% | 52.63% |
| Total Current Assets | 27.16% | 171.42% | 151.68% | -72.95% | -72.25% |
|
|
|||||
| Total Current Assets | 27.16% | 171.42% | 151.68% | -72.95% | -72.25% |
| Net Property, Plant & Equipment | -82.32% | -73.49% | -72.46% | -27.11% | -32.04% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -20.40% | 0.63% | 0.42% | -3.42% | -1.20% |
| Total Assets | -10.06% | 76.08% | 84.28% | -62.11% | -69.83% |
|
|
|||||
| Total Accounts Payable | -80.81% | -51.09% | -28.38% | -31.24% | -58.18% |
| Total Accrued Expenses | 53.28% | 44.66% | 25.14% | -34.22% | -52.12% |
| Short-term Debt | 192.16% | -84.05% | -91.66% | -50.31% | -95.98% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.67% | 7.07% | 7.47% | 8.15% | -19.59% |
| Total Finance Division Other Current Liabilities | -73.37% | -66.11% | 24.78% | -30.09% | -27.93% |
| Total Other Current Liabilities | -73.37% | -66.11% | 24.78% | -30.09% | -27.93% |
| Total Current Liabilities | -27.02% | -40.61% | -21.84% | -33.54% | -56.60% |
|
|
|||||
| Total Current Liabilities | -27.02% | -40.61% | -21.84% | -33.54% | -56.60% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 192.16% | -84.05% | -91.66% | -50.31% | -95.98% |
| Capital Leases | -50.67% | -43.99% | -38.71% | -36.01% | -34.00% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -33.94% | -41.30% | -28.71% | -37.90% | -51.76% |
|
|
|||||
| Common Stock & APIC | -1.19% | 1.42% | 2.73% | 4.03% | 7.36% |
| Retained Earnings | -0.86% | 1.29% | 1.49% | -4.92% | -10.00% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -351.69% | 780.42% | 564.98% | -109.90% | -78.93% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 71,850.00% | 0.00% | -99.60% | -99.69% | -99.70% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 71,850.00% | 0.00% | -99.60% | -99.69% | -99.70% |
|
|
|||||
| Total Common Equity | -351.69% | 780.42% | 564.98% | -109.90% | -78.93% |
| Total Preferred Equity | 71,850.00% | 0.00% | -99.60% | -99.69% | -99.70% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 52.43% | 788.01% | 3,754.38% | -103.89% | -84.77% |
|
|
|||||